Imatib 100mg (Imatinib) for CML Leukemia

Name: Imatib 100mg
Brand: Imatinib
SKU: 530
Availability: InStock

Imatib 100mg is a prescription medicine used to treat several types of cancer. It is primarily used to treat blood cancers (chronic myeloid leukaemia and acute lymphocytic leukaemia) and gastrointestinal stromal tumours. The active ingredient in the medicine is Imatinib mesylate, which targets specific proteins involved in the growth and spread of cancer cells. This, in turn, helps slow or stop the progression of the disease. Imatinib can also be used to treat dermatofibrosarcoma protuberans, a type of skin tumour, and aggressive systemic mastocytosis, a bone marrow condition. The Imatinib formulation is usually prescribed as part of a long-term treatment regimen under strict medical guidance.

Precautions

Do not take Imatib 100mg if you are allergic to Imatinib or any of the non-medicinal ingredients in the formulation. You should avoid using this medication if you are breastfeeding. You must not breastfeed for 15 days before taking an Imatinib formulation and for 15 days after the last dose. The anticancer medication can enter breast milk and harm your baby. Speak to your healthcare specialist to understand the best way to feed your baby during treatment with Imatinib. Do not drink grapefruit juice at any time while using Imatib cancer medicine.

Before taking Imatib 100mg, patients should inform their healthcare specialist of their complete medical history. Special precautions may include:

Heart problems: Patients with heart disease or at risk of heart failure should exercise caution.
Kidney disease: Dose adjustments may be required.
Liver problems: Imatib 100mg may impact the liver; therefore, regular liver function tests are recommended.
Imatinib can contribute to swelling, especially around the eyes and ankles.
Osteonecrosis has been uncommonly reported in adults and children treated with Imatinib 100. Osteonecrosis is the death of bone tissue because of inadequate blood flow. The condition leads to tiny cracks in the bone, causing it to collapse.
While taking this anticancer medication, it is necessary to use a highly effective contraceptive method. Continue with your contraceptive method for 15 days after ending treatment.
If you are trying to have a baby, speak to your healthcare specialist. You may be advised not to use this anticancer medication while you are trying to have a child if you are already receiving Imatinib mesylate before you try to have a child. If you are already receiving Imatib 100mg, your healthcare professional may advise you to discontinue the anticancer medication before you try to have a child. Imatinib mesylate may affect your ability to have children. Discuss with your healthcare provider if this is a concern for you.
The cancer medication can cause dizziness, vision problems, or fatigue before performing any tasks that require your complete attention.
Certain medications may interact with Imatinib. These may include ketoconazole, itraconazole, clarithromycin, oxcarbazepine, carbamazepine, primidone, phenytoin, simvastatin, pimozide, anti-hypertensive agents, heart medicines, rifampicin, St.John’s Wort, dexamethasone, cyclosporine, acetaminophen, warfarin, and levothyroxine.

Dosage Instructions

Side Effects

Side effects

Side effects of Imatib 100mg include weight loss, change in taste, no appetite, sore sin mouth, heart burn, constipation, headache, dizziness, weakness, feeling tired, cough, bone pain, muscle tension, bone, cough, joint pain, swelling, unusual hir loss or thinning, muscle tension, bone pain, increased tears in the eyes, nosebleeds, skin more sensitive to sun, trouble sleeping, drowsiness, tingling pain, numbness in the hands, feet, legs, night sweats, redness on the face or other areas of the skin.

If any of these side effects affect you severely, talk to your healthcare specialist straight away.

How to Use

How to use ?

Imatinib 100mg should only be initiated by a healthcare specialist specialised in the treatment of malignancies and malignant sarcomas. The exact dosage and duration of treatment depend on the patient’s condition, treatment response, and overall health. In general, the dose should be taken orally with a large glass of water and with food immediately after a meal to lower the possibility of gastrointestinal problems. Prescribed doses of 400 mg and 600 mg are to be consumed once daily, while 800 mg per day should be used as 400 mg twice daily. For those who have a problem swallowing, the tablet should be crushed and swallowed with water. The treatment should resume for as long as patients benefit from this medication.

Taking Imatinib with a meal will help protect you from stomach problems. Swallow the tablet with a glass of water. It is always recommended to take the medicine at the same time every day for optimal effectiveness. The anticancer medication needs to be taken regularly without missing any doses, as missing doses or stopping treatment abruptly can reduce its effectiveness. You should keep taking the medication every day for as long as your healthcare specialist prescribes it to you.

Infographics

FAQ

What is Imatinib and what condition does it treat?

Imatinib is a targeted cancer therapy medication classified as a tyrosine kinase inhibitor. Imatib 100mg contains imatinib as its active ingredient and is primarily prescribed to treat chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and gastrointestinal stromal tumors (GIST). This anticancer medicine works by blocking specific proteins that promote cancer cell growth. Imatinib revolutionized cancer treatment by offering an oral medication alternative that targets cancer cells while sparing healthy tissue. This kinase inhibitor is also used for certain rare blood disorders and specific tumor types as determined by oncologists.

How does Imatinib work in the body?

Imatinib functions by selectively blocking abnormal tyrosine kinase enzymes that signal cancer cells to multiply uncontrollably. In chronic myeloid leukemia, the BCR-ABL protein drives cancerous growth, and Imatib 100mg specifically inhibits this protein's activity. This targeted therapy approach stops leukemia cells from dividing while allowing normal blood cells to recover. Unlike traditional chemotherapy that affects all rapidly dividing cells, this tyrosine kinase inhibitor precisely targets the molecular abnormality causing the cancer. For GIST tumors, imatinib blocks the KIT protein that fuels tumor growth, offering a mechanism-based treatment approach.

How long does Imatib 100mg take to work?

Response times to Imatib 100mg vary depending on the condition being treated and individual patient factors. For chronic myeloid leukemia, initial blood count improvements often appear within four to twelve weeks, though achieving a complete hematologic response may take three months. Molecular responses indicating deeper remission develop gradually over six to eighteen months of continuous imatinib therapy. GIST patients may notice symptom relief and tumor stabilization within two to four months. This tyrosine kinase inhibitor requires consistent daily dosing to maintain therapeutic blood levels, and treatment effectiveness is monitored through regular blood tests and imaging studies.

When and how should I take Imatib 100mg?

Take Imatib 100mg exactly as your oncologist prescribes, typically once daily with a full meal and large glass of water. Taking this tyrosine kinase inhibitor with food reduces stomach irritation and improves absorption. Swallow tablets whole without crushing or breaking them. Maintain consistent timing each day to keep steady imatinib levels in your bloodstream. If you miss a dose and it's within twelve hours of your usual time, take it immediately; otherwise, skip it and resume your regular schedule. Never double doses. Store tablets at room temperature away from moisture. Always follow your healthcare provider's specific dosing instructions for your condition.

Is Imatib 100mg safe for long-term use?

Imatib 100mg is designed for extended therapy, and many patients take this tyrosine kinase inhibitor safely for years under medical supervision. Long-term imatinib treatment has proven effective for maintaining remission in chronic myeloid leukemia and controlling GIST tumors. Regular monitoring through blood tests helps detect and manage potential side effects before they become serious. Some patients experience mild ongoing effects like muscle cramps or fluid retention that can be managed with supportive care. Oncologists continuously assess the benefit-to-risk ratio throughout treatment. Most individuals tolerate long-term imatinib therapy well, with quality of life remaining stable or improving as the cancer stays controlled.

Can I take Imatib 100mg with other medicines?

Imatib 100mg can interact with numerous medications, so your healthcare team must review all drugs and supplements before starting this tyrosine kinase inhibitor. Certain antibiotics, antifungals, and heart medications significantly affect imatinib blood levels. St. John's Wort reduces effectiveness, while grapefruit juice increases drug concentration and side effect risk. Warfarin interactions require careful monitoring. Some cholesterol medications, anti-seizure drugs, and even common antacids can interfere with this cancer therapy. Acetaminophen is generally safe for pain relief. Maintain an updated medication list including vitamins, herbal products, and over-the-counter drugs for your oncology team to review regularly.

How does Imatib 100mg compare to similar medicines in its class?

Imatib 100mg was the pioneering tyrosine kinase inhibitor for chronic myeloid leukemia and remains a first-line treatment option. Newer kinase inhibitors like dasatinib, nilotinib, and bosutinib were developed subsequently, often called second-generation agents. While these alternatives may work faster or overcome imatinib resistance in some patients, imatinib maintains advantages including longer safety data, lower cost as a generic medication, and excellent effectiveness for most newly diagnosed patients. This cancer therapy established the proof-of-concept for targeted molecular treatment. Choice between imatinib and newer options depends on disease characteristics, patient tolerance, and resistance patterns observed through monitoring.

Is the generic Imatinib as effective as branded versions?

Generic imatinib, including Imatib 100mg, delivers the same therapeutic effectiveness as the original branded Gleevec. Regulatory authorities in the USA, UK, and Australia require generic medications to demonstrate bioequivalence, meaning they release the same amount of active ingredient into the bloodstream at the same rate. Clinical studies confirm that generic tyrosine kinase inhibitors produce equivalent response rates in chronic myeloid leukemia and GIST treatment. The active pharmaceutical ingredient is identical; differences lie only in inactive components and appearance. Generic imatinib offers significant cost savings while maintaining the treatment quality that transformed cancer therapy, making this life-saving medication more accessible worldwide.

Where can I buy Imatib 100mg online safely?

PremiumRxDrugs.comprovides a safe, licensed platform for purchasing Imatib 100mg online with delivery to the USA, UK, Australia, and many other countries. This established online pharmacy has served patients for over ten years, supplying only authentic, manufacturer-sourced imatinib and other cancer medications. The pharmacy requires valid prescriptions, ensuring appropriate medical oversight for this tyrosine kinase inhibitor therapy. Competitive pricing on both generic and branded formulations makes long-term cancer treatment more affordable. Discreet packaging protects your privacy, while worldwide shipping options include free delivery on qualifying orders. The prescription management system simplifies reordering this essential medication.

Why do patients choose PremiumRxDrugs.com for Imatib 100mg?

Patients prefer PremiumRxDrugs.com for their Imatib 100mg supply because the pharmacy combines medication authenticity with practical convenience for long-term cancer therapy. Being fully licensed means every tyrosine kinase inhibitor tablet meets pharmaceutical quality standards. The competitive pricing structure significantly reduces the financial burden of continuous imatinib treatment compared to local pharmacy costs. International patients in the USA, UK, and Australia appreciate reliable worldwide shipping with discreet packaging that respects privacy. The easy prescription management and reorder system eliminates the stress of running out of this critical cancer medication. Over a decade of trusted service has built a reputation for dependable supply of authentic medicines.

What are the common side effects of Imatinib?

Common side effects of imatinib include fluid retention causing facial puffiness or ankle swelling, muscle cramps (especially at night), nausea, diarrhea, and skin rashes. Many patients experience fatigue, headaches, and joint discomfort during treatment with this tyrosine kinase inhibitor. Mild to moderate side effects typically improve as your body adjusts to the medication. Less common but notable effects include changes in liver function tests, low blood cell counts, and vision changes. Most adverse reactions are manageable with supportive care or dose adjustments. Serious side effects like severe fluid accumulation, chest pain, or unusual bleeding require immediate medical attention. Regular monitoring helps identify issues early.

Who should avoid taking Imatinib?

Individuals with known hypersensitivity to imatinib or any tablet components should not use this tyrosine kinase inhibitor. Pregnant women must avoid imatinib due to significant fetal harm risks; effective contraception is essential during treatment and after discontinuation. Breastfeeding mothers should not take this cancer medication as it passes into breast milk. Patients with severe liver impairment require careful evaluation before starting imatinib therapy. Those with heart conditions, especially congestive heart failure, need specialized monitoring due to fluid retention risks. Children under two years typically should not receive this medication. Anyone taking strong CYP3A4 inducers may need alternative treatments due to reduced imatinib effectiveness.

SKU	530
Generic For	Imatinib
Strength	100mg
Active Ingredient	Imatinib

Imatib 100mg